
### [NCIT:C26859](http://purl.obolibrary.org/obo/NCIT_C26859)
**Label:** Pleural Disorder

**Subclasses:** [NCIT:C136399](http://purl.obolibrary.org/obo/NCIT_C136399) (Pleural Malignant Mesothelioma by AJCC v8 Stage), [NCIT:C3603](http://purl.obolibrary.org/obo/NCIT_C3603) (Benign Pleural Neoplasm), [NCIT:C4499](http://purl.obolibrary.org/obo/NCIT_C4499) (Pleural Adenomatoid Tumor), [NCIT:C3547](http://purl.obolibrary.org/obo/NCIT_C3547) (Malignant Pleural Neoplasm), [NCIT:C4457](http://purl.obolibrary.org/obo/NCIT_C4457) (Pleural Solitary Fibrous Tumor), [NCIT:C45660](http://purl.obolibrary.org/obo/NCIT_C45660) (Pleural Well Differentiated Papillary Mesothelioma), [NCIT:C45663](http://purl.obolibrary.org/obo/NCIT_C45663) (Pleural Sarcomatoid Mesothelioma), [NCIT:C45662](http://purl.obolibrary.org/obo/NCIT_C45662) (Pleural Epithelioid Mesothelioma), [NCIT:C45665](http://purl.obolibrary.org/obo/NCIT_C45665) (Pleural Biphasic Mesothelioma), [NCIT:C45687](http://purl.obolibrary.org/obo/NCIT_C45687) (Pleural Lymphoma), [NCIT:C45664](http://purl.obolibrary.org/obo/NCIT_C45664) (Pleural Desmoplastic Mesothelioma), [NCIT:C45666](http://purl.obolibrary.org/obo/NCIT_C45666) (Localized Pleural Malignant Mesothelioma), [NCIT:C136374](http://purl.obolibrary.org/obo/NCIT_C136374) (Pleural Malignant Mesothelioma by AJCC v7 Stage), [NCIT:C9351](http://purl.obolibrary.org/obo/NCIT_C9351) (Pleural Mesothelioma), [NCIT:C38006](http://purl.obolibrary.org/obo/NCIT_C38006) (Pneumothorax), [NCIT:C136403](http://purl.obolibrary.org/obo/NCIT_C136403) (Stage III Pleural Malignant Mesothelioma AJCC v8), [NCIT:C6648](http://purl.obolibrary.org/obo/NCIT_C6648) (Stage III Pleural Malignant Mesothelioma AJCC v7), [NCIT:C8707](http://purl.obolibrary.org/obo/NCIT_C8707) (Recurrent Pleural Malignant Mesothelioma), [NCIT:C27563](http://purl.obolibrary.org/obo/NCIT_C27563) (Non-Neoplastic Pleural Disorder), [NCIT:C6647](http://purl.obolibrary.org/obo/NCIT_C6647) (Stage II Pleural Malignant Mesothelioma AJCC v7), [NCIT:C136406](http://purl.obolibrary.org/obo/NCIT_C136406) (Stage IV Pleural Malignant Mesothelioma AJCC v8), [NCIT:C6649](http://purl.obolibrary.org/obo/NCIT_C6649) (Stage IV Pleural Malignant Mesothelioma AJCC v7), [NCIT:C3332](http://purl.obolibrary.org/obo/NCIT_C3332) (Pleural Neoplasm), [NCIT:C6644](http://purl.obolibrary.org/obo/NCIT_C6644) (Pleural Lipoma), [NCIT:C27384](http://purl.obolibrary.org/obo/NCIT_C27384) (Pleural Carcinomatosis), [NCIT:C136400](http://purl.obolibrary.org/obo/NCIT_C136400) (Stage I Pleural Malignant Mesothelioma AJCC v8), [NCIT:C6646](http://purl.obolibrary.org/obo/NCIT_C6646) (Stage I Pleural Malignant Mesothelioma AJCC v7), [NCIT:C3579](http://purl.obolibrary.org/obo/NCIT_C3579) (Metastatic Malignant Neoplasm in the Pleura), [NCIT:C136402](http://purl.obolibrary.org/obo/NCIT_C136402) (Stage II Pleural Malignant Mesothelioma AJCC v8), [NCIT:C7376](http://purl.obolibrary.org/obo/NCIT_C7376) (Pleural Malignant Mesothelioma), [NCIT:C45695](http://purl.obolibrary.org/obo/NCIT_C45695) (Pleural Epithelioid Hemangioendothelioma), [NCIT:C26859](http://purl.obolibrary.org/obo/NCIT_C26859) (Pleural Disorder), 

**Class expressions from DL-Learner:**

- [NCIT:C26859](http://purl.obolibrary.org/obo/NCIT_C26859) (Pleural Disorder) 98.48%
- [NCIT:C3332](http://purl.obolibrary.org/obo/NCIT_C3332) (Pleural Neoplasm) 93.94%
- [NCIT:C3547](http://purl.obolibrary.org/obo/NCIT_C3547) (Malignant Pleural Neoplasm) 83.33%
- [NCIT:C9351](http://purl.obolibrary.org/obo/NCIT_C9351) (Pleural Mesothelioma) 80.30%
- [NCIT:C7376](http://purl.obolibrary.org/obo/NCIT_C7376) (Pleural Malignant Mesothelioma) 75.76%
- [NCIT:C4456](http://purl.obolibrary.org/obo/NCIT_C4456) (Malignant Mesothelioma) and [NCIT:C9351](http://purl.obolibrary.org/obo/NCIT_C9351) (Pleural Mesothelioma) 75.76%
- [NCIT:C3547](http://purl.obolibrary.org/obo/NCIT_C3547) (Malignant Pleural Neoplasm) and [NCIT:C4456](http://purl.obolibrary.org/obo/NCIT_C4456) (Malignant Mesothelioma) 75.76%
- [NCIT:C3332](http://purl.obolibrary.org/obo/NCIT_C3332) (Pleural Neoplasm) and [NCIT:C4456](http://purl.obolibrary.org/obo/NCIT_C4456) (Malignant Mesothelioma) 75.76%
- [NCIT:C26859](http://purl.obolibrary.org/obo/NCIT_C26859) (Pleural Disorder) and [NCIT:C4456](http://purl.obolibrary.org/obo/NCIT_C4456) (Malignant Mesothelioma) 75.76%
- [NCIT:C3576](http://purl.obolibrary.org/obo/NCIT_C3576) (Malignant Thoracic Neoplasm) and [NCIT:C4456](http://purl.obolibrary.org/obo/NCIT_C4456) (Malignant Mesothelioma) and [NCIT:C9351](http://purl.obolibrary.org/obo/NCIT_C9351) (Pleural Mesothelioma) 75.76%
- [NCIT:C3547](http://purl.obolibrary.org/obo/NCIT_C3547) (Malignant Pleural Neoplasm) and [NCIT:C4456](http://purl.obolibrary.org/obo/NCIT_C4456) (Malignant Mesothelioma) and [NCIT:C9351](http://purl.obolibrary.org/obo/NCIT_C9351) (Pleural Mesothelioma) 75.76%
- [NCIT:C3332](http://purl.obolibrary.org/obo/NCIT_C3332) (Pleural Neoplasm) and [NCIT:C3576](http://purl.obolibrary.org/obo/NCIT_C3576) (Malignant Thoracic Neoplasm) and [NCIT:C4456](http://purl.obolibrary.org/obo/NCIT_C4456) (Malignant Mesothelioma) 75.76%
- [NCIT:C26859](http://purl.obolibrary.org/obo/NCIT_C26859) (Pleural Disorder) and [NCIT:C3576](http://purl.obolibrary.org/obo/NCIT_C3576) (Malignant Thoracic Neoplasm) and [NCIT:C4456](http://purl.obolibrary.org/obo/NCIT_C4456) (Malignant Mesothelioma) 75.76%
- [NCIT:C26859](http://purl.obolibrary.org/obo/NCIT_C26859) (Pleural Disorder) and [NCIT:C3406](http://purl.obolibrary.org/obo/NCIT_C3406) (Thoracic Neoplasm) and [NCIT:C4456](http://purl.obolibrary.org/obo/NCIT_C4456) (Malignant Mesothelioma) 75.76%
- [NCIT:C26859](http://purl.obolibrary.org/obo/NCIT_C26859) (Pleural Disorder) and [NCIT:C3263](http://purl.obolibrary.org/obo/NCIT_C3263) (Neoplasm by Site) and [NCIT:C4456](http://purl.obolibrary.org/obo/NCIT_C4456) (Malignant Mesothelioma) 75.76%


